Director Williams Anthony was granted 2,169 shares, increasing direct ownership by 27% to 10,271 units (SEC Form 4)
4 - Howard Hughes Holdings Inc. (0001981792) (Issuer)
Insider Trading
Delayed 3mAll SEC insider transactions as they're filed.
Signed out · 3-min delay · Sign up for real-time
- Director Lachman Thomas Cecil was granted 3,290 shares, increasing direct ownership by 134% to 5,754 units (SEC Form 4)
4 - Howard Hughes Holdings Inc. (0001981792) (Issuer)
- President, CEO Goldthorpe Edward J. bought $98,364 worth of shares (13,738 units at $7.16), increasing direct ownership by 16% to 99,878 units (SEC Form 4)
4 - BCP Investment Corp (0001372807) (Issuer)
- Amendment: SEC Form 4 filed by Director Weisenburger Randall J
4/A - Corsair Gaming, Inc. (0001743759) (Issuer)
- Director Valantine Hannah was granted 3,990 shares, exercised 2,808 shares at a strike of $41.73 and sold $341,524 worth of shares (5,004 units at $68.25) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 9,259 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Cook Jennifer E. was granted 3,990 shares, sold $2,752,270 worth of shares (39,363 units at $69.92) as part of a pre-agreed trading plan and exercised 37,167 shares at a strike of $12.28, increasing direct ownership by 27% to 8,383 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Lo Andrew was granted 3,990 shares, increasing direct ownership by 28% to 18,079 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Homcy Charles J was granted 3,990 shares, increasing direct ownership by 0.44% to 919,876 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Daniels Ronald J was granted 3,990 shares, increasing direct ownership by 23% to 20,981 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Aguiar Eric was granted 3,990 shares, increasing direct ownership by 61% to 10,579 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Ellis Andrea was granted 3,990 shares, increasing direct ownership by 21% to 22,579 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Momtazee James C was granted 3,990 shares, increasing direct ownership by 26% to 19,070 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Hassan Fred was granted 3,990 shares, increasing direct ownership by 15% to 29,879 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Mccormick Frank was granted 3,990 shares, increasing direct ownership by 61% to 10,579 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Satvat Ali J. was granted 3,990 shares, increasing direct ownership by 2% to 169,983 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- Director Dachille Douglas A. was granted 3,990 shares, increasing direct ownership by 61% to 10,579 units (SEC Form 4)
4 - BridgeBio Pharma, Inc. (0001743881) (Issuer)
- VP, Chief Accounting Officer Cotterman Ryan Joseph was granted 2,063 shares (SEC Form 4)
4 - Ingevity Corp (0001653477) (Issuer)
- PRESIDENT AND CIO Springer Robert C sold $1,041,512 worth of shares (89,631 units at $11.62), decreasing direct ownership by 14% to 573,743 units (SEC Form 4)
4 - Sunstone Hotel Investors, Inc. (0001295810) (Issuer)